have convincingly illustrated that monocytes, isolated from the peripheral blood of patients with colon cancer, demonstrate pronounced upregulation of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), a key enzyme in the glycolytic cascade (1). Here, PFKFB3 is linked to malignant colon neoplasm.